BioCentury
ARTICLE | Clinical News

Nobori update

June 6, 2005 7:00 AM UTC

Terumo subsidiary Terumo Europe NV (Leuven, Belgium) began the international NOBORI I trial in 360 patients. The equivalence trial will compare Nobori with Taxus Express2 drug-eluting stent from Bos...